During the past decade, Yaxley Group Practice conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yaxley Group Practice" are "Diabetes Type 2" (1 trials) and "Diabetes, Type I" (1 trials). Many other conditions were trialed in "Yaxley Group Practice" in a lesser frequency.

Most popular intervention types in "Yaxley Group Practice" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Active comparator" (1 trials), "Technosphere Insulin" (1 trials) and "Technosphere® Insulin Inhalation Powder" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yaxley Group Practice" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yaxley Group Practice". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Yaxley Group Practice, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yaxley Group Practice, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".